Search

Your search keyword '"Corcorran, Maria A."' showing total 38 results
Start Over Author "Corcorran, Maria A."
38 results on '"Corcorran, Maria A."'

5. Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives

Author

Austin, Elizabeth J., Corcorran, Maria A., Briggs, Elsa S., Frost, Madeline C., Behrends, Czarina N., Juarez, Alexa M., Frank, Noah D., Healy, Elise, Prohaska, Stephanie M., LaKosky, Paul A., Kapadia, Shashi N., Perlman, David C., Schackman, Bruce R., Jarlais, Don C. Des, Williams, Emily C., and Glick, Sara N.

Published
2022
Full Text
View/download PDF

18. Chronic Hepatitis B and HIV Coinfection

Author

Corcorran, Maria A. and Kim, H. Nina

Subjects
Invited Review
Abstract

Hepatitis B virus (HBV) infection is common among people with HIV owing to shared modes of viral transmission. Compared with individuals with HBV infection alone, people with HIV/HBV coinfection experience an accelerated progression of liver disease, including increased risks for hepatocellular carcinoma, liver-related mortality, and all-cause mortality. Therefore, HBV screening and appropriate treatment are crucial for people with HIV. This article reviews the epidemiology, natural history, and management of HIV/HBV coinfection, as well as recommendations for prevention of HBV infection among people with HIV.

Published
2023

19. Availability of and Obstacles to Providing COVID-19 Vaccinations at Syringe Services Programs in the United States, 2021

Author

Des Jarlais, Don C., primary, Behrends, Czarina N., additional, Corcorran, Maria A., additional, Glick, Sara N., additional, Perlman, David C., additional, Kapadia, Shashi N., additional, Lu, Xinlin, additional, Feelemyer, Jonathan, additional, LaKosky, Paul, additional, Prohaska, Stephanie M., additional, and Schackman, Bruce R., additional

Published
2022
Full Text
View/download PDF

21. Correlates of 90-day Mortality Among People Who Do and Do Not Inject Drugs with Infective Endocarditis in Seattle, Washington

Author

Corcorran, Maria A, primary, Stewart, Jenell, additional, Lan, Kristine, additional, Gupta, Ayushi, additional, Glick, Sara N, additional, Seshadri, Chetan, additional, Koomalsingh, Kevin J, additional, Gibbons, Edward F, additional, Harrington, Robert D, additional, Dhanireddy, Shireesha, additional, and Kim, H Nina, additional

Published
2022
Full Text
View/download PDF

22. Awareness of HIV Pre-Exposure Prophylaxis (PrEP) and Correlates of Interest in PrEP Among HIV-negative People Who Inject Drugs and Access Syringe Services in Seattle, Washington

Author

Corcorran, Maria A., Scott, John D., Tinsley, Joe, Wald, Anna, and Glick, Sara N.

Subjects
Washington, Pharmaceutical Preparations, Syringes, HIV Seropositivity, Humans, HIV Infections, Pre-Exposure Prophylaxis, Substance Abuse, Intravenous, Article
Abstract

HIV pre-exposure prophylaxis (PrEP) is safe and effective for use in people who inject drugs (PWID), but PrEP is underutilized in this population. We assessed awareness of PrEP and correlates of interest in PrEP among PWID in Seattle, Washington.This study analyzed data from a 2019 survey of PWID at 3 Seattle-area syringe service programs (SSPs). We used descriptive statistics to compare PrEP-aware and unaware PWID and multivariable Poisson regression with robust standard errors to estimate adjusted prevalence ratios (APR) for interest in PrEP.Among 348 HIV-negative PWID, ≤1% were currently taking PrEP, 51% were PrEP aware and 46% were interested in PrEP. Interest in PrEP was inversely associated with prior PrEP awareness (APR 0.58, 95% CI 0.45 - 0.74); however, interest in PrEP was high among PWID meeting pre-specified risk criteria for HIV (APR 1.41, 95% CI 1.06 - 1.88).Our results suggest increasing awareness of PrEP may not be sufficient to promote PrEP uptake among PWID, and further efforts are needed to understand perceptions of risk for HIV, determinants of PrEP use, and to investigate successful strategies for PrEP implementation and delivery in this marginalized population.Supplemental data for this article is available online at https://doi.org/10.1080/10826084.2021.2012688 .

Published
2021

24. Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine.

Author

Corcorran, Maria A., Austin, Elizabeth J., Behrends, Czarina N., Briggs, Elsa S., Frost, Madeline C., Juarez, Alexa M., Frank, Noah D., Healy, Elise, Prohaska, Stephanie M., LaKosky, Paul A., Kapadia, Shashi N., Perlman, David C., Schackman, Bruce R., Des Jarlais, Don C., Williams, Emily C., and Glick, Sara N.

Abstract

Background: We explored syringe service program (SSP) perspectives on barriers, readiness, and programmatic needs to support coronavirus disease 2019 (COVID-19) vaccine uptake among people who use drugs. Methods: We conducted an exploratory qualitative study, leveraging an existing sample of SSPs in the United States. Semistructured, in-depth interviews were conducted with SSP staff between February and April 2021. Interviews were analyzed using a Rapid Assessment Process, an intensive, iterative process that allows for rapid analysis of time-sensitive qualitative data. Results: Twenty-seven SSPs completed a qualitative interview. Many SSP respondents discussed that COVID-19 vaccination was not a priority for their participants because of competing survival priorities, and respondents shared concerns that COVID-19 had deepened participant mistrust of health care. Most SSPs wanted to participate in COVID-19 vaccination efforts; however, they identified needed resources, including adequate space, personnel, and training, to implement successful vaccine programs. Conclusions: Although SSPs are trusted resources for people who use drugs, many require additional structural and personnel support to address barriers to COVID-19 vaccination among their participants. Funding and supporting SSPs in the provision of COVID-19 prevention education and direct vaccine services should be a top public health priority. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

26. Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S.

Author

Frost, Madeline C., primary, Sweek, Elsa W., additional, Austin, Elizabeth J., additional, Corcorran, Maria A., additional, Juarez, Alexa M., additional, Frank, Noah D., additional, Prohaska, Stephanie M., additional, LaKosky, Paul A., additional, Asher, Alice K., additional, Broz, Dita, additional, Jarlais, Don C. Des, additional, Williams, Emily C., additional, and Glick, Sara N., additional

Published
2021
Full Text
View/download PDF

27. Prolonged persistence of PCR-detectable virus during an outbreak of SARS-CoV-2 in an inpatient geriatric psychiatry unit in King County, Washington

Author

Corcorran, Maria A., primary, Olin, Svaya, additional, Rani, Golo, additional, Nasenbeny, Keri, additional, Constantino-Shor, Cheri, additional, Holmes, Charity, additional, Quinnan-Hostein, Laura, additional, Solan, William, additional, Snoeyenbos Newman, Gretchen, additional, Roxby, Alison C., additional, Greninger, Alexander L., additional, Jerome, Keith R., additional, Neme, Santiago, additional, Lynch, John B., additional, Dellit, Timothy H., additional, and Cohen, Seth A., additional

Published
2021
Full Text
View/download PDF

28. Prevalence of COVID-19 Infection and Outcomes Among Symptomatic Healthcare Workers in Seattle, Washington

Author

Mani, Nandita S, Budak, Jehan Z, Lan, Kristine F, Bryson-Cahn, Chloe, Zelikoff, Allison, Barker, Gwendolyn E C, Grant, Carolyn W, Hart, Kristi, Barbee, Carrie J, Sandoval, Marissa D, Dostal, Christine L, Corcorran, Maria, Ungerleider, Hal M, Gates, Jeff O, Olin, Svaya V, Bryan, Andrew, Hoffman, Noah G, Marquis, Sara R, Harvey, Michelle L, Nasenbeny, Keri, Mertens, Kathleen, Chew, Lisa D, Greninger, Alexander L, Jerome, Keith R, Pottinger, Paul S, Dellit, Timothy H, Liu, Catherine, Pergam, Steven A, Neme, Santiago, Lynch, John B, Kim, H Nina, and Cohen, Seth A

Subjects
Washington, AcademicSubjects/MED00290, employee health, healthcare workers, SARS-CoV-2, Health Personnel, Major Article, Prevalence, COVID-19, Humans, Delivery of Health Care
Abstract

Background Healthcare workers (HCW) serving on the front lines of the coronavirus disease 2019 (COVID-19) pandemic have been at increased risk for infection due to SARS-CoV-2 in some settings. Healthcare-acquired infection has been reported in similar epidemics, but there are limited data on the prevalence of COVID-19 among HCWs and their associated clinical outcomes in the United States. Methods We established two high-throughput employee testing centers in Seattle, Washington with drive-through and walk-through options for symptomatic employees in the University of Washington Medicine system and its affiliated organizations. Using data from these testing centers, we report the prevalence of SARS-CoV-2 infection among symptomatic employees and describe the clinical characteristics and outcomes among employees with COVID-19. Results Between March 12 and April 23, a total of 3,477 symptomatic employees were tested for COVID-19 at two employee testing centers; 185 (5.3%) employees tested positive for COVID-19. The prevalence of SARS-CoV-2 was similar when comparing frontline HCWs (5.2%) to non-frontline staff (5.5%). Among 174 positive employees reached for follow-up at least 14 days after diagnosis, 6 reported COVID-related hospitalization; all recovered. Conclusions During the study period, we observed that the prevalence of positive SARS-CoV-2 tests among symptomatic HCWs was comparable to that of symptomatic non-frontline staff. Reliable and rapid access to testing for employees is essential to preserve the health, safety, and availability of the healthcare workforce during this pandemic and to facilitate the rapid return of SARS-CoV-2 negative employees to work.

Published
2020

30. Awareness and Correlates of HIV Pre-Exposure Prophylaxis (PrEP) Among HIV-negative People Who Access Syringe Services in Seattle, Washington.

Author

Corcorran, Maria A., Scott, John D., Tinsley, Joe, Wald, Anna, and Glick, Sara N.

Subjects
*HIV prevention, *HIV infections, *NEEDLE exchange programs, *SYRINGES, *CONFIDENCE intervals, *HEALTH literacy, *DESCRIPTIVE statistics, *DISEASE prevalence, *PREVENTIVE medicine, *POISSON distribution
Abstract

HIV pre-exposure prophylaxis (PrEP) is safe and effective for use in people who inject drugs (PWID), but PrEP is underutilized in this population. We assessed awareness of PrEP and correlates of interest in PrEP among PWID in Seattle, Washington. This study analyzed data from a 2019 survey of PWID at 3 Seattle-area syringe service programs (SSPs). We used descriptive statistics to compare PrEP-aware and unaware PWID and multivariable Poisson regression with robust standard errors to estimate adjusted prevalence ratios (APR) for interest in PrEP. Among 348 HIV-negative PWID, ≤1% were currently taking PrEP, 51% were PrEP aware and 46% were interested in PrEP. Interest in PrEP was inversely associated with prior PrEP awareness (APR 0.58, 95% CI 0.45 − 0.74); however, interest in PrEP was high among PWID meeting pre-specified risk criteria for HIV (APR 1.41, 95% CI 1.06 − 1.88). Our results suggest increasing awareness of PrEP may not be sufficient to promote PrEP uptake among PWID, and further efforts are needed to understand perceptions of risk for HIV, determinants of PrEP use, and to investigate successful strategies for PrEP implementation and delivery in this marginalized population. Supplemental data for this article is available online at https://doi.org/10.1080/10826084.2021.2012688. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

31. 702. Characteristics of Infective Endocarditis (IE) and Predictors of 90-day Mortality Among People Who Do and Do Not Inject Drugs with IE in Seattle, Washington

Author

Corcorran, Maria A, primary, Stewart, Jenell C, additional, Lan, Kristine F, additional, Gupta, Ayushi, additional, Muggli, Tanner N, additional, Sharninghausen, Jody C, additional, Takasugi, Jordan, additional, Tietjen, Ty J, additional, Glick, Sara N, additional, Seshadri, Chetan, additional, Koomalsingh, Kevin, additional, Gibbons, Edward F, additional, Harrington, Robert, additional, Dhanireddy, Shireesha, additional, and Kim, H Nina, additional

Published
2020
Full Text
View/download PDF

34. Prevalence of Coronavirus Disease 2019 Infection and Outcomes Among Symptomatic Healthcare Workers in Seattle, Washington

Author

Mani, Nandita S, primary, Budak, Jehan Z, additional, Lan, Kristine F, additional, Bryson-Cahn, Chloe, additional, Zelikoff, Allison, additional, Barker, Gwendolyn E C, additional, Grant, Carolyn W, additional, Hart, Kristi, additional, Barbee, Carrie J, additional, Sandoval, Marissa D, additional, Dostal, Christine L, additional, Corcorran, Maria, additional, Ungerleider, Hal M, additional, Gates, Jeff O, additional, Olin, Svaya V, additional, Bryan, Andrew, additional, Hoffman, Noah G, additional, Marquis, Sara R, additional, Harvey, Michelle L, additional, Nasenbeny, Keri, additional, Mertens, Kathleen, additional, Chew, Lisa D, additional, Greninger, Alexander L, additional, Jerome, Keith R, additional, Pottinger, Paul S, additional, Dellit, Timothy H, additional, Liu, Catherine, additional, Pergam, Steven A, additional, Neme, Santiago, additional, Lynch, John B, additional, Kim, H Nina, additional, and Cohen, Seth A, additional

Published
2020
Full Text
View/download PDF

35. Hyperammonemia syndrome due to Ureaplasma infection after liver‐kidney transplant

Author

Cannon, Chase A., primary, Corcorran, Maria A., additional, Shaw, Kathryn W., additional, Montenovo, Martin, additional, Sibulesky, Lena, additional, Reyes, Jorge D., additional, Rayhill, Stephen C., additional, Larson, Anne M., additional, Kritek, Patricia A., additional, Giovanni, Shewit, additional, Castro, Iris, additional, Arora, Nayan, additional, and Rakita, Robert M., additional

Published
2020
Full Text
View/download PDF

38. Chronic hepatitis B and HIV coinfection.

Author

Corcorran MA and Kim N

Subjects
Humans, Hepatitis B virus, Hepatitis B, Chronic diagnosis, Coinfection epidemiology, Hepatitis B epidemiology, HIV Infections epidemiology, Liver Neoplasms
Abstract

Hepatitis B virus (HBV) infection is common among people with HIV owing to shared modes of viral transmission. Compared with individuals with HBV infection alone, people with HIV/HBV coinfection experience an accelerated progression of liver disease, including increased risks for hepatocellular carcinoma, liver-related mortality, and all-cause mortality. Therefore, HBV screening and appropriate treatment are crucial for people with HIV. This article reviews the epidemiology, natural history, and management of HIV/HBV coinfection, as well as recommendations for prevention of HBV infection among people with HIV.

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results